NANETS produces a monthly eNewsletter, Net News. Net News contains information on recent NET disease research, guidelines and resources. It also highlights NET continuing medical education (CME) programming, medical society developments, member accomplishments and news from other NET organizations. Have news to share? Contact us! Net News is a benefit of membership in NANETS. Not a member? Subscribe now!


NANETS leaders have compiled this resource for providers to inform the care of NET patients during the COVID-19 pandemic. Please click on the image below to read the full document.

Screenshot 2020 04 02 at 5.49.10 PM

The Panel Discussion on NET Patient Care in the Era of COVID-19 held Thursday, April 2, 2020, 8:00 - 9:15 pm ET is available now. An audio version will be available shortly.

The discussion focuses on key areas of importance to medical professionals and their patients, with recommendations from leading members of the NET medical community. Thank you to our panelists: Pamela L. Kunz, MD, University School of Medicine; Daniel Halperin, MD, University of Texas MD Anderson Cancer Center; James Howe, MD, University of Iowa, Carver College of Medicine; and Emily Bergsland, MD, University of California, San Francisco School of Medicine.

Additional resources are available on the NANETS COVID-19 Resource Page.

The North American Neuroendocrine Tumor Society was established in 2007 with the mission of furthering neuroendocrine tumor disease diagnosis, treatment and management. Since its inception, NANETS has remained dedicated to this mission through the provision of increased education and research opportunities. It is through research grants NANETS engages medical professionals in the early part of their careers to foster further exploration and advancement of NET diagnosis and treatment.

Since 2009, NANETS has awarded $1.5 million in research grants to 22 medical professionals. This year, NANETS is pleased to offer three research grants to support innovative research initiatives and encourage young researchers and scientific clinicians to become NET specialists.

NANETS Basic/Translational Science Investigator (BTSI)

The NANETS Basic/Translational Science Investigator (BTSI) is awarded to scientists at the end of their fellowship or in the beginning of their faculty appointment, who are predominantly focused on lab-based, basic/translational research. The BTSI is intended to encourage the scientific inquiry in the field of basic/translational science as it relates to NETs. Learn more and submit an application.

NANETS Clinical Investigator Scholarship (NCIS)

The NANETS Clinical Investigator Scholarship (NCIS) encourages clinicians at the end of their fellowship or beginning of their faculty appointment to pursue a clinical career focused on neuroendocrine tumors. The NCIS emphasizes both the professional development of the scientific clinician (whose time is primarily dedicated to patient care) and the potential of the project to directly impact NET patients. Learn more and submit an application.

NANETS Theranostics Investigator Grant (NTIG)

The NANETS Theranostics Investigator Grant (NTIG) encourages early career professionals to pursue research focused in theranostics and neuroendocrine tumors. This grant will further the exploration of theranostics and its potential to improve the diagnosis and management of neuroendocrine tumors. Given the recent and substantial advances in the area of nuclear theranostics in particular, there is an urgent need to support more of the high-quality research proposals that we receive in this field.  Learn more and submit an application.

               New online grant submission system this year

NANETS is using an online system for the submission of applications. The submission period begins April 1, 2020 through June 12, 2020. The new system allows for editing submissions until the June 12 deadline. Visit our Research Grants Page for more information and to submit an application. For questions, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..